Roche Global Head Of Pharma Partnering Dan Zabrowski: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Swiss firm’s R&D alliances comprise more than 80 deals in 20 countries.
You may also be interested in...
Pfizer Seeks New Homes For Assets Orphaned By R&D Reorg
New head of out-licensing takes on prospects cast off in Pfizer’s recent exit from non-“high priority” therapeutic areas.
Pfizer Seeks New Homes For Assets Orphaned By R&D Reorg
New head of out-licensing takes on prospects cast off in Pfizer’s recent exit from non-“high priority” therapeutic areas.
Roche Global Head Of Pharma Partnering Dan Zabrowski: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Zabrowski’s number one concern? Filling the gap when products go off patent.